Nikita Midamba

PsychologyMedicineSocial Sciences

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials”.

Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials

The Lancet Respiratory Medicine(2022)10.1016/s2213-2600(22)00434-9

N/A

3.9DataRank · unranked

127 citations

Félix Ratjen, Renee Russell, Scott H. Donaldson, Kristin A. Riekert, Gregory S. Sawicki +91 more

118 Research coordination perceptions of a coached home spirometry protocol: ongoing experiences with the OUTREACH study

Journal of Cystic Fibrosis(2023)10.1016/s1569-1993(23)01052-4

N/A

0DataRank · unranked

0 citations

Jason H. Greenberg, N. Reid, B. Fogarty, Nikita Midamba, A. Berlinski +3 more

Trial design of bacteriophage therapy for nontuberculous mycobacteria pulmonary disease in cystic fibrosis: The POSTSTAMP study

Journal of Cystic Fibrosis(2025)10.1016/j.jcf.2025.03.669

N/A

0DataRank · unranked

2 citations

Stacey L. Martiniano, Valerie K. Lovell, Brian Vestal, Katie R. Poch, Silvia M. Caceres +45 more